Alice Brown

Company: Purespring Therapeutics

Job title: CSO

Seminars:

Panel Discussion & Audience Roundtable: Advancing Therapeutics in Glomerular Diseases: What’s Next? 2:30 pm

Discuss the need to identify reliable surrogate markers for other glomerular diseases and potential avenues for development and standardization Discuss what can be learned from the established biomarkers in IgA nephropathy to improve patient outcomes in other glomerular diseases Examine the variability in pathology and clinical presentation among glomerular disease patients, and what strategies can…Read more

day: Pre-Conference Focus Day

Exploring the Recent Developments in Gene Therapy for Glomerular Diseases 1:30 pm

Examine recent advancements in gene therapy for glomerular diseases, focusing on novel vector technologies and targeted delivery systems designed to restore kidney function by addressing the underlying genetic drivers of disease Explore PureSpring Therapeutics’ innovative approach using adeno-associated virus (AAV) vectors to enable precision targeting of podocyte-specific pathways, highlighting its potential to revolutionize treatment for…Read more

day: Pre-Conference Focus Day